Peptide Library

5-Amino-1MQ

Selective NNMT inhibitor that reduces fat mass by increasing NAD+ and cellular energy expenditure, without affecting appetite.

ACE-031

Acceleron Pharma soluble ActRIIB-Fc decoy receptor, myostatin/activin ligand trap; DMD Phase 2 2011 trial terminated.

ACTH

Pituitary hormones instruct the adrenal glands to produce cortisol; synthetic fragments are used for adrenal testing.

AHK-Cu

Copper Peptide – Copper Complexed Tripeptide Alanine-Histidine-Lysine (AHK-Cu, Copper Tripeptide-3), studied for follicle stimulation and dermal papilla cell survival.

AICAR

Original motion simulant, AMPK activator; increases running endurance in sedentary mice by 44%; banned by WADA for 2009 years.

ANP

Endogenous 28 amino acid cardiac hormone secreted by atrial myocytes that drives natriuresis, vasodilation, and renin-aldosterone inhibition.

AOD-9604

Growth hormone-modified fragment specifically targeting fat metabolism, without the growth-promoting effects of full-length GH.

ARA-290

Erythropoietin-engineered 11 amino acid peptide that preserves tissue protection without increasing red blood cell counts, developed for neuropathic pain.

ASC30

GeLi's investigational small-molecule biased GLP-1 receptor agonist competes with orforglipron via oral administration.

ASC35

GeLai Research's GLP-1/GIP dual receptor agonist, a tirzepatide-class candidate in early clinical development.

ASC36

Galmed's investigational amylin analog competes in the amylin agonist category with cagrilintide, petrelintide, and eloralintide.

AVA6000

Avacta's FAP-activated doxorubicin peptide-drug conjugate demonstrates significant disease control rates in the Phase I FOCUS trial of tumor microenvironment-activated chemotherapy.

AVA6103

Avacta's second PRECISION platform peptide-drug conjugate, featuring a FAP-cleavable linker to mask exatecan, achieves first patient dosing in Phase I FOCUS-01.

Abaloparatide

FDA approves PTHrP synthetic analog to stimulate new bone formation in postmenopausal women.

Ac-SDKP

Endogenous tetrapeptide; cleaved from thymosin β4, exhibiting broad antifibrotic activity across the heart, kidney, lung, and liver.

Adamax

Semax derivative with N-terminal acetylation and C-terminal adamantane modification, engineered for enhanced blood-brain barrier penetration and BDNF upregulation.

Adatide

Research channel peptide list: no PubMed footprint with peer review, no characterization in mainstream literature, and no FDA-approved pathway.

Adiponectin

244 amino acid adipocytes secrete hormones; levels drop during obesity.

Adipotide

Experimental fat-targeting peptide selectively disrupts blood vessels in white adipose tissue; showed significant fat loss in primate studies but was discontinued due to nephrotoxicity.

Adrenomedullin

Endogenous 52 amino acid vasodilator peptide, CGRP/Calcitonin family.